Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev

Virology

Volumn 222, Issue 2, 1996, Pages 423-429

  Hua, Jan ^a   Cafffey, James J ^a,b   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN;

ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA SEQUENCE; VIRUS REPLICATION;

EID: 0030586764     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0439     Document Type: Article

References (35)

1. Berger, J., Hauber, J., Hauber, R., Geiger, R., and Cullen, B. R. (1988). Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66, 1-10.
2. Bogerd, H. P., Fridell, R. A., Madore, S., and Cullen, B. R. (1995). Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82, 485-494.
3. Buchbinder, S. P., Katz, M. H., Hessol, N. A., O'Malley, P. M., and Holmberg, S. D. (1994). Long-term HIV-1 infection without immunologic progression. AIDS 8, 1123-1128.
4. Cao, Y., Qin, L., Zhang, L., Safrit, J., and Ho, D. D. (1995). Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332, 201-208.
5. Coffin, J. M. (1995). HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
6. Cullen, B. R. (1987). Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152, 684-704.
7. Cullen, B. R. (1995). Regulation of HIV gene expression. AIDS 9, S19-S32.
8. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., Lawson, V. A., Crowe, L. S., Maerz, A., Sonza, S., Learmont, J., Sullivan, J. S., Cunningham, A., Dwyer, D., Dowton, D., and Mills, J. (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
9. De Leys, R., Vanderborght, B., Vanden Haesevelde, M., Heyndrickx, L., van Geel, A., Wauters, C., Bernaerts, R., Saman, E., Nijs, P., Willems, B., Taelman, H., van der Groen, G., Piot, P., Tersmette, T., Huisman, J. G., and Van Heuverswyn, H. (1990). Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J. Virol. 64, 1207-1216.
10. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T., and Pavlakis, G. N. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86, 1495-1499.
11. Fields, S., and Song, O-K. (1989). A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.
12. Fischer, U., Meyer, S., Teufel, M., Heckel, C., Lührmann, R., and Rautmann, G. (1994). Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced PNA. EMBO J. 13, 4105-4112.
13. Rscher, U., Huber, J., Boelens, W. C., Mattaj, I. W., and Lührmann, R. (1995). The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82, 475-483.
14. Fritz, C. C., Zapp, M. L., and Green, M. R. (1995). A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376, 530-533.
15. Ghosh, S. K., Fultz, P. N., Keddie, E., Saag, M. S., Sharp, P. M., Hahn, B. H., and Shaw, G. M. (1993). A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology 194, 858-864.
16. Gurgo, C., Guo, H-G., Franchini, G., Aldovini, A., Collalti, E., Farrell, K., Wong-Staal, F., Gallo, R. C., and Reitz, M. S., Jr. (1988). Envelope sequences of two new United States HIV-1 isolates. Virology 164, 531-536.
17. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
18. Harrer, T., Harrer, E., Kalams, S. A., Elbeik, T., Staprans, S. I., Feinberg, M. B., Cao, Y., Ho, D. D., Yilma, T., Caliendo, A. M., Johnson, R. P., Buchbinder, S. P., and Walker, B. D. (1996). Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses 12, 585-592.
19. Hope, T. J., Bond, B. L., McDonald, D., Klein, N. P., and Parslow, T. G. (1991). Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type 1 Rex are functionally interchangeable and share an essential peptide motif. J Virol. 65, 6001-6007.
20. Huet, T., Cheynier, R., Meyerhans, A., Roelants, G., and Wain-Hobson, S. (1990). Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature 345, 356-359.
21. Iversen, A. K. N., Shpaer, E. G., Rodrigo, A. G., Hirsch, M. S., Walker, B. D., Sheppard, H. W., Merigan, T. C., and Mullins, J. I. (1995). Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J. Virol. 69, 5743-5753.
22. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., and Desrosiers, R. C. (1995). Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228-232.
23. Kubota, S., Duan, L., Furuta, R. A., Hatanaka, M., and Pomerantz, R. J. (1996). Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein. J. Virol. 70, 1282-1287.
24. Malim, M. H., and Cullen, B. R. (1991). HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency. Cell 65, 241-248.
25. Malim, M. H., Böhnlein, S., Hauber, J., and Cullen, B. R. (1989a). Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 58, 205-214.
26. Malim, M. H., Hauber, J., Le, S-Y., Maizel, J. V., and Cullen, B. R. (1989b). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
27. Malim, M. H., McCarn, D. F., Tiley, L. S., and Cullen, B. R. (1991). Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65, 4248-4254.
28. Meyer, B. E., Meinkoth, J. L., and Malim, M. H. (1996). Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: Identification of a family of transferable nuclear export signals. J. Virol. 70, 2350-2359.
29. Oram, J. D., Downing, R. G., Roff, M., Clegg, J. C. S., Serwadda, D., and Carswell, J. W. (1990). Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates. AIDS Res. Hum. Retroviruses 6, 1073-1078.
30. Pomerantz, R. J., Trono, D., Feinberg, M. B., and Baltimore, D. (1990). Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell 61, 1271-1276.
31. Rinaldo, C., Huang, X-L, Fan, Z, Ding, M., Beltz, L., Panicali, D., Mazzara, G., Liebmann, J., Cottrill, M., and Gupta, P. (1995). High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69, 5838-5842.
32. Venkatesh, L. K., and Chinnadurai, G. (1990). Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology 178, 327-330.
33. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S., and Shaw, G. M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-126.
34. Wen, W., Meinkoth, J. L., Tsien, R. Y., and Taylor, S. S. (1995). Identification of a signal for rapid export of proteins from the nucleus. Cell 82, 463-473.
35. Zapp, M. L., Hope, T. J., Parslow, T. G., and Green, M. R. (1991). Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: A dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci. USA 88, 7734-7738. VIROLOGY 222, 430-439 (1996)